M3541 in Combination With Radiotherapy in Solid Tumors

Stopped The study was terminated early per sponsor decision to halt further development of M3541 due to pharmaceutical and PK/pharmacodynamics properties that precluded further clinical development.

Conditions

• Solid Tumors

Interventions

• DRUG: M3541
• RADIATION: Palliative Radiotherapy (RT)

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

• [object Object]